肺吸虫病诊治现状的分析研究  

Analyse of the Diagnosis and Treatment of Paragonimiasis

作　　者：李彦[1] 孙黎[1] 马传良[1] 邓银[1] 

机构地区：[1]四川省疾病预防控制中心,四川成都610041

出　　处：《四川医学》2015年第9期1279-1283,共5页Sichuan Medical Journal

摘　　要：目的分析肺吸虫病的诊治现状,提高临床的诊治水平。方法对465例肺吸虫患者的临床资料做统计、分析。结果肺吸虫病以学龄儿童发病为多。临床表现以皮下包块或结节、呼吸系统症状为多。末梢血的嗜酸细胞百分比、流行病学资料、抗体的检测是其诊断的重要依据。通过吡喹酮足剂量正规疗程的抗虫治疗,肺吸虫病可以达到临床治愈。目前本病临床误诊率高,导致患者看病周折反复,延误了病情,增加了患者精神和经济负担。结论嗜酸细胞百分比、流行病学资料、抗体的检测对本病的诊断有着重要价值,吡喹酮是治疗本病安全有效的药物。加强临床医生对本病的认知,减少临床误诊势在必行。Objective To analyze the status quo of the diagnosis and treatment of paragonimiasis, and to improve the lev-el of clinical diagnosis and treatment. Methods The clinical data of 465 cases of paragonimiasis patients were analyzed statistical-ly. Results The incidence of paragonimiasis was high mainly for school-age children. Subcutaneous masses or nodules and respir-atory symptoms were the most common clinical manifestations. Peripheral blood eosinophil percentage, epidemiological data, and antibody detection were important for diagnosis. Clinical cure could be achieved by full dose standard treatment with praziquantel for paragonimiasis. Currently, the high mis-diagnosis rate delayed the treatment, turned over the progress of recovery, and in-creased the mental and economic burden of patients. Condusion The eosinophil percentage, epidemiological data, and antibody detection have important values for diagnosis Praziquantel is a safe and effective medicine. It is imperative for the clinician to im-prove the cognition of the disease and to reduce clinical misdiagnosis.

关 键 词：肺吸虫 诊断 误诊 吡喹酮 

分 类 号：R532.2[医药卫生—内科学]